Holen Sie sich die Stockscreener-App
12.80
1.35%
0.17
Handel nachbörslich:
12.79
-0.01
-0.08%
Schlusskurs vom Vortag:
$12.63
Offen:
$12.64
24-Stunden-Volumen:
21,635
Relative Volume:
0.40
Marktkapitalisierung:
$89.89M
Einnahmen:
$100.44M
Nettoeinkommen (Verlust:
$-133.16M
KGV:
-0.4969
EPS:
-25.76
Netto-Cashflow:
$-94.85M
1W Leistung:
+3.56%
1M Leistung:
+13.07%
6M Leistung:
+79.52%
1J Leistung:
+41.44%
1-Tages-Spanne:
$12.38
$12.80
1-Wochen-Bereich:
$11.70
$12.80
52-Wochen-Spanne:
$5.005
$18.70
Atara Biotherapeutics Inc Stock (ATRA) Company Profile
Firmenname
Atara Biotherapeutics Inc
Sektor
Branche
Telefon
805-623-4211
Adresse
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA
Vergleichen Sie ATRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATRA
Atara Biotherapeutics Inc
|
12.80 | 86.66M | 100.44M | -133.16M | -94.85M | -25.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Atara Biotherapeutics Inc Stock (ATRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-11-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-09 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-07-20 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-07-13 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-13 | Herabstufung | Stifel | Buy → Hold |
| 2022-05-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-05-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-11-10 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-30 | Eingeleitet | Evercore ISI | Outperform |
| 2020-06-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-11-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-09-27 | Herabstufung | Goldman | Neutral → Sell |
| 2019-09-16 | Herabstufung | Jefferies | Buy → Hold |
| 2019-06-04 | Hochstufung | Citigroup | Sell → Neutral |
| 2019-05-30 | Eingeleitet | ROTH Capital | Buy |
| 2019-05-23 | Eingeleitet | Stifel | Buy |
| 2019-01-23 | Eingeleitet | Mizuho | Buy |
| 2018-04-10 | Eingeleitet | JP Morgan | Overweight |
| 2018-03-16 | Eingeleitet | Guggenheim | Neutral |
| 2018-03-05 | Bestätigt | Jefferies | Buy |
| 2018-02-28 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-02-15 | Herabstufung | Citigroup | Neutral → Sell |
| 2018-01-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2017-10-06 | Fortgesetzt | Goldman | Neutral |
Alle ansehen
Atara Biotherapeutics Inc Aktie (ATRA) Neueste Nachrichten
Greg Ciongoli appointed as new chair of Atara Biotherapeutics board - Investing.com
Atara Biotherapeutics Announces Changes to Its Board of Directors - Business Wire
Building trade automation scripts for Atara Biotherapeutics Inc.2025 Valuation Update & Fast Exit and Entry Trade Guides - Newser
Using portfolio simulators with Atara Biotherapeutics Inc. includedWeekly Gains Summary & Technical Buy Zone Confirmations - Newser
Published on: 2025-09-03 12:24:36 - Newser
Market reaction to Atara Biotherapeutics Inc.’s recent newsJuly 2025 Decliners & Smart Money Movement Alerts - Newser
How to manage a losing position in Atara Biotherapeutics Inc.Market Trend Review & Smart Investment Allocation Insights - Newser
Leading vs lagging indicators on Atara Biotherapeutics Inc. performance2025 Bull vs Bear & Weekly Breakout Watchlists - Newser
Trend analysis for Atara Biotherapeutics Inc. this week2025 Price Momentum & High Accuracy Swing Trade Signals - Newser
Is now a turning point for Atara Biotherapeutics Inc.2025 Bull vs Bear & AI Forecasted Stock Moves - Newser
Evaluating Atara Biotherapeutics Inc. with trendline analysis2025 Volume Leaders & Safe Capital Growth Trade Ideas - Newser
Will breakout in Atara Biotherapeutics Inc. lead to full recoveryLayoff News & Weekly Top Stock Performers List - Newser
Published on: 2025-09-03 04:06:27 - Newser
Using Ichimoku Cloud for Atara Biotherapeutics Inc. technicalsJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
Does Atara Biotherapeutics Inc. have declining or rising EPS2025 Market Sentiment & Free Accurate Trade Setup Notifications - khodrobank.com
Will Atara Biotherapeutics Inc. stock go up soonBond Market & Risk Controlled Swing Trade Alerts - Newser
Key metrics from Atara Biotherapeutics Inc.’s quarterly dataWeekly Earnings Recap & Safe Entry Point Identification - Newser
Should I invest in Atara Biotherapeutics Inc. before earnings2025 Market Sentiment & AI Forecast for Swing Trade Picks - khodrobank.com
Published on: 2025-09-02 14:34:30 - Newser
Published on: 2025-09-02 10:22:30 - Newser
How to read the order book for Atara Biotherapeutics Inc.2025 Fundamental Recap & AI Driven Stock Reports - Newser
Is Atara Biotherapeutics Inc. stock influenced by commodity prices2025 Trade Ideas & High Conviction Buy Zone Picks - khodrobank.com
Is Atara Biotherapeutics Inc. stock risky to hold nowWeekly Risk Report & Fast Gain Swing Alerts - khodrobank.com
Is Atara Biotherapeutics Inc. being accumulated by smart money2025 Support & Resistance & Entry Point Strategy Guides - khodrobank.com
Atara Biotherapeutics Inc. stock daily chart insightsWeekly Trend Summary & High Accuracy Trade Signal Alerts - Newser
Published on: 2025-09-01 03:37:34 - Newser
Reversal indicators forming on Atara Biotherapeutics Inc. stockJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - Newser
Published on: 2025-08-31 21:18:25 - Newser
Risk adjusted return profile for Atara Biotherapeutics Inc. analyzed2025 AllTime Highs & Free Technical Confirmation Trade Alerts - Newser
Ranking Atara Biotherapeutics Inc. among high performing stocks via toolsCPI Data & Accurate Entry and Exit Point Alerts - Newser
Chart based analysis of Atara Biotherapeutics Inc. trends2025 Performance Recap & Weekly High Momentum Picks - Newser
Published on: 2025-08-31 13:53:27 - Newser
What’s the recovery path for long term holders of Atara Biotherapeutics Inc.2025 Biggest Moves & AI Powered Buy/Sell Recommendations - Newser
Will Atara Biotherapeutics Inc. price bounce be sustainable2025 Volatility Report & Real-Time Chart Pattern Alerts - Newser
What’s next for Atara Biotherapeutics Inc. stock price2025 Market Sentiment & Smart Investment Allocation Tips - Newser
Momentum Traders Eye Atara Biotherapeutics Inc. for Quick Bounce getLinesFromResByArray error: size == 0 - kangso.co.kr
Should I invest in Atara Biotherapeutics Inc. before earnings getLinesFromResByArray error: size == 0 - 더경남뉴스
Trend Dashboard Flags Atara Biotherapeutics Inc. As Potential Swing Trade getLinesFromResByArray error: size == 0 - 더경남뉴스
Using data filters to optimize entry into Atara Biotherapeutics Inc.2025 Investor Takeaways & Target Return Focused Picks - Newser
Analyzing Atara Biotherapeutics Inc. with risk reward ratio chartsSell Signal & AI Powered Market Entry Strategies - Newser
Multi asset correlation models including Atara Biotherapeutics Inc.2025 Analyst Calls & Free Accurate Trade Setup Notifications - Newser
Will Atara Biotherapeutics Inc. outperform the marketTrade Analysis Summary & Smart Money Movement Tracker - Newser
Finanzdaten der Atara Biotherapeutics Inc-Aktie (ATRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Atara Biotherapeutics Inc-Aktie (ATRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Grant-Huerta Yanina | Chief Accounting Officer |
Aug 18 '25 |
Sale |
11.61 |
1,809 |
21,009 |
35,258 |
| Panacea Innovation Ltd | 10% Owner |
Aug 15 '25 |
Buy |
12.19 |
55,000 |
670,422 |
1,405,000 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):